BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Uddin MA, Akhter MS, Kubra KT, Barabutis N. P53 deficiency potentiates LPS-Induced acute lung injury in vivo. Curr Res Physiol 2020;3:30-3. [PMID: 32724900 DOI: 10.1016/j.crphys.2020.07.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhan Z, Chai L, Lei Q, Zhou X, Wang Y, Deng H, Lv Y, Li W. Two-photon ratiometric fluorescent probe for imaging of hypochlorous acid in acute lung injury and its remediation effect. Anal Chim Acta 2021;1187:339159. [PMID: 34753573 DOI: 10.1016/j.aca.2021.339159] [Reference Citation Analysis]
2 Barabutis N. P53 in acute respiratory distress syndrome. Cell Mol Life Sci 2020;77:4725-7. [PMID: 32886127 DOI: 10.1007/s00018-020-03629-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
3 Uddin MA, Akhter MS, Kubra KT, Barabutis N. Induction of the NEK family of kinases in the lungs of mice subjected to cecal ligation and puncture model of sepsis. Tissue Barriers 2021;9:1929787. [PMID: 34151722 DOI: 10.1080/21688370.2021.1929787] [Reference Citation Analysis]
4 Uddin MA, Akhter MS, Kubra KT, Siejka A, Barabutis N. Metformin in acute respiratory distress syndrome: An opinion. Exp Gerontol 2021;145:111197. [PMID: 33310152 DOI: 10.1016/j.exger.2020.111197] [Reference Citation Analysis]
5 Barabutis N. Unfolded protein response in the COVID-19 context. Aging Health Res 2021;1:100001. [PMID: 33330852 DOI: 10.1016/j.ahr.2020.100001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
6 Kubra KT, Uddin MA, Akhter MS, Barabutis N. Luminespib counteracts the Kifunensine-induced lung endothelial barrier dysfunction. Curr Res Toxicol 2020;1:111-5. [PMID: 33094291 DOI: 10.1016/j.crtox.2020.09.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
7 Uddin MA, Barabutis N. P53 in the impaired lungs. DNA Repair (Amst) 2020;95:102952. [PMID: 32846356 DOI: 10.1016/j.dnarep.2020.102952] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
8 Bortot B, Romani A, Ricci G, Biffi S. Exploiting Extracellular Vesicles Strategies to Modulate Cell Death and Inflammation in COVID-19. Front Pharmacol 2022;13:877422. [DOI: 10.3389/fphar.2022.877422] [Reference Citation Analysis]
9 Zauli G, Tisato V, Secchiero P. Rationale for Considering Oral Idasanutlin as a Therapeutic Option for COVID-19 Patients. Front Pharmacol 2020;11:1156. [PMID: 32848765 DOI: 10.3389/fphar.2020.01156] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Barabutis N. Unfolded Protein Response: A Regulator of the Endothelial Barrier. Endocr Metab Sci 2021;3:100092. [PMID: 33796874 DOI: 10.1016/j.endmts.2021.100092] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Barabutis N, Marinova M, Solopov P, Uddin MA, Croston GE, Reinheimer TM, Catravas JD. Protective Mechanism of the Selective Vasopressin V1A Receptor Agonist Selepressin against Endothelial Barrier Dysfunction. J Pharmacol Exp Ther 2020;375:286-95. [PMID: 32943478 DOI: 10.1124/jpet.120.000146] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Cui X, Pan G, Chen Y, Guo X, Liu T, Zhang J, Yang X, Cheng M, Gao H, Jiang F. The p53 pathway in vasculature revisited: A therapeutic target for pathological vascular remodeling? Pharmacol Res 2021;169:105683. [PMID: 34019981 DOI: 10.1016/j.phrs.2021.105683] [Reference Citation Analysis]
13 Kubra KT, Uddin MA, Akhter MS, Leo AJ, Siejka A, Barabutis N. P53 mediates the protective effects of metformin in inflamed lung endothelial cells. Int Immunopharmacol 2021;:108367. [PMID: 34794886 DOI: 10.1016/j.intimp.2021.108367] [Reference Citation Analysis]
14 Uddin MA, Akhter MS, Kubra KT, Barabutis N. Hsp90 inhibition protects brain endothelial cells against LPS-induced injury. Biofactors 2022. [PMID: 35266593 DOI: 10.1002/biof.1833] [Reference Citation Analysis]
15 Barabutis N, Akhter MS, Kubra KT, Uddin MA. Restoring the endothelial barrier function in the elderly. Mech Ageing Dev 2021;196:111479. [PMID: 33819492 DOI: 10.1016/j.mad.2021.111479] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Barabutis N. Unfolded protein response in endothelial injury. Cell Cycle 2022;:1-4. [PMID: 35617133 DOI: 10.1080/15384101.2022.2082024] [Reference Citation Analysis]
17 Uddin MA, Akhter MS, Kubra KT, Whitaker KE, Shipley SL, Smith LM, Barabutis N. Hsp90 inhibition protects the brain microvascular endothelium against oxidative stress. Brain Disord 2021;1:100001. [PMID: 33569547 DOI: 10.1016/j.dscb.2020.100001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]